Search Results

You searched for : pembrolizumab  

Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 Antibody

As the ZM008-001 clinical trial progresses, the medical community eagerly awaits the results, which could lead the way for a new era in cancer ...
Jun 13

Evaxion Biotech announces Clinical Collaboration to evaluate Keytruda in melanoma patients

Latest news updates...
Oct 26

Adagene Announces the Third Clinical Trial Collaboration with Merck to Advance Anti-CD137 Agonist, ADG106

Latest Pharma Update...
Aug 23

Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC

Immutep was granted Fast Track designation for efti to treat 1st line HNSCC patients by the US FDA in early April 2021. ...
Jul 12

M2GEN announces new collaboration with Merck to advance Cancer therapies

Another pharma collaboration for the advancement of cancer therapies ...
Mar 22

BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid tumors

BioInvent and Transgene, today announced they have received regulatory approval in Belgium for a clinical trial application (CTA) for a Phase l/lla study of ...
Dec 21

KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival

...
Dec 16

KEYTRUDA plus LENVIMA met the trial’s primary endpoint of progression-free survival

LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma...
Nov 10

BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMTâ„¢

Median OS of 13.3 months has been observed in the Phase I/IIa study for patients treated with Bria-IMTâ„¢ in combination with immune ...
Oct 21

PharmAbcine entered into a strategic partnership with Samsung Biologic

PharmAbcine is a clinical-stage biotech company developing fully human therapeutic antibodies to treat cancer and neovascular disease...
Sep 22

PharmAbcine signs a CMO contract with Binex for Olinvacimab production

Binex will produce olinvacimab at its new 5,000L production line...
Sep 03

Merck’s KEYTRUDA Receives Two New Approvals in Japan

Keytruda would be soon launched in Japan for the treatment of cancerous tumors...
Aug 27

Singapore cancer drug ETC-159 advances further in clinical trials

First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours ...
Jul 31

PharmAbcine signs manufacturing agreement with Binex

PharmAbcine signs long-term contract manufacturing organization agreement for Olinvacimab with Binex ...
Jun 27

Merck Innovates Breakthrough in Cancer Care

Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 ...
May 14

IASLC World Conference on Lung Cancer--Press Briefing Summary from Sunday, September 8th

...
Sep 13

Three-Year Survival Update: Pembrolizumab Effective as First-Line Therapy for Advanced Non-Small Cell Lung Cancer

First-line pembrolizumab monotherapy provides durable long-term overall survival benefit compared to chemotherapy, according to data presented today by Dr. M. Reck, Lung Clinic ...
Sep 10

17 Matching result(s) found!

-Advertisements-




Trending Now

We have more infection-prevention options now but are they actual choices for the people?July 19, 2024
New humidity-driven membrane to remove carbon dioxide from the airJuly 19, 2024
Introducing the World's First Consent-Based Data-Sharing Framework Built on Open Standards: The Affinidi Iota Framework July 19, 2024
The Power of Green Spaces: Evidence That Parks May Delay Cognitive DeclineJuly 19, 2024
Strengthening Healthcare in India: The Push for Better Coverage with Ayushman BharatJuly 19, 2024
SARV Events & Celebrations Shines at "Edu-Bizz Leadership Summit & Awards 24July 18, 2024
UAE launches global initiative to build 10 hospitals to address critical healthcare gaps as part of Zayed Humanitarian Legacy InitiativeJuly 18, 2024
Geetanjali Homestate Expands Global Presence with the Launch of Geetanjali GlobalJuly 18, 2024
Changes projected in marine fish communities due to climate changeJuly 18, 2024
Understanding the Chandipura Virus Outbreak in Gujarat: A Critical OverviewJuly 18, 2024
Landmark Study Links Severe Endometriosis to Increased Risk of Ovarian CancerJuly 18, 2024
Equipping Healthcare Professionals for Global Opportunities: GIMS Partners with NSDCJuly 18, 2024
Hormone Modulating Therapy for Breast Cancer and Its Link to Lower Alzheimer’s RiskJuly 18, 2024
Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, JapanJuly 17, 2024
FedEx to empower youth with digital skilling programJuly 17, 2024
Putting people first means following Gandhi's TalismanJuly 17, 2024
American Oncology Institute (AOI) Launches #BreaktheHabit Campaign to Raise Awareness on Head & Neck cancerJuly 17, 2024
Chamraj Tea Estate Launches New Nilgiri Tea Blends: ‘Master Blend,’ ‘Master Blend Ginger Tea,’ and ‘Master Blend Lemon Tea’July 16, 2024
How a Fiber-Rich Diet and Gut Parasites Can Improve Your HealthJuly 16, 2024
LinkedIn: A Double-Edged Sword for Professional GrowthJuly 16, 2024